Evidence map›Paper›PMID 40445505›Full record

ArticleJournal of medical toxicology : official journal of the American College of Medical Toxicology2025

A Case of Angiotensin II Utilization for Refractory Shock in a Polysubstance Overdose.

Brian W Gilbert, Charles S Wilson, Nicholas Kim, Tessa R Cox, Melissa V Ortiz

Abstract readCase Reports
In one paragraph

Article in Journal of medical toxicology : official journal of the American College of Medical Toxicology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Brian W GilbertDepartment of Pharmacy, Emergency Medicine, Wesley Medical Center, 550 N. Hillside Street, Wichita, KS, 67214, USA. Brian.gilbert.pharmd@gmail.com.ORCID http://orcid.org/0000-0002-1385-7500
Charles S WilsonDepartment of Pharmacy, Surgical Critical Care, Wesley Medical Center, 550 N. Hillside Street, Wichita, KS, 67214, USA.
Nicholas KimDepartment of Pharmacy, Critical Care, Wesley Medical Center, 550 N. Hillside Street, Wichita, Tessa R. Cox, PharmD, 67214, KS, USA.
Tessa R CoxDepartment of Pharmacy, Medical Critical Care, Wesley Medical Center, 550 N. Hillside Street, Wichita, KS, 67214, USA.
Melissa V OrtizDepartment of Emergency Medicine, Wesley Medical Center, 550 N. Hillside Street, Wichita, KS, 67214, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Amlodipine and quetiapine are widely utilized medications that are generally well-tolerated at therapeutic doses. However, overdoses can lead to severe, life-threatening cardiovascular effects, leading to refractory vasoplegia. The management of poly-ingestion overdoses is challenging and often requires aggressive, multimodal treatment strategies especially when the causative agent is unknown. In this case report, a 38-year-old male intentionally ingested a large amount of amlodipine and quetiapine resulting in refractory shock despite high doses of vasopressors, calcium, and insulin therapy. After conventional therapies failed, the administration of exogenous angiotensin II (Ang II), a vasoconstrictor traditionally used for septic shock, led to a marked improvement in the patient's blood pressure and stabilization of hemodynamics. Sixty minutes after initiation of Ang II, the patient's mean arterial pressure (MAP) improved, allowing for the weaning of other vasopressors and a gradual reduction in insulin therapy. This case highlights the potential role of Ang II as a salvage therapy in polysubstance ingestions when other therapies fail.

Indexed as

AmlodipineAngiotensin IIAntipsychotic AgentsQuetiapine FumarateShockVasoconstrictor AgentsAdultDrug OverdoseHumansMaleSuicide, AttemptedTreatment OutcomeAmlodipineAngiotensin IIAntipsychotic AgentsQuetiapine FumarateVasoconstrictor Agents

Identifiers

PMID40445505
PMCPMC12205107

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.